IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Nabriva Therapeutics PLC

CUSIP: G63637105 | 137 institutional holders

Quarters

Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2022

Sterling Investment Advisors, Ltd.3,000
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Sterling Investment Advisors, Ltd.
3,000$10.0%GrowthLowBerwyn, PA2022-08-05